Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Am J Reprod Immunol. 2011 Jan 18;65(6):597–609. doi: 10.1111/j.1600-0897.2010.00968.x

Fig. 3.

Fig. 3

Cytokine/chemokine production profile of DC following delivery of ovarian cancer lysates in soluble or NP-associated form. Ovarian cancer lysate encapsulated in NP activates DC to produce pro-inflammatory cytokines such as IL-1β, IL-6, IFNγ, TNFα, G-CSF and RANTES, an effect not associated with soluble Ag delivery or non-specific NP stimulation [media= DC only, NP= DC loaded with empty nanoparticle; L= DC loaded with equimolar soluble lysate; NPL= DC loaded with NP-encapsulated lysate].